KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Vertex Pharmaceuticals (VRTX) Revenue: 2009-2024

Historic Revenue for Vertex Pharmaceuticals (VRTX) over the last 16 years, with Dec 2024 value amounting to $11.0 billion.

  • Vertex Pharmaceuticals' Revenue rose 10.99% to $3.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $11.7 billion, marking a year-over-year increase of 10.33%. This contributed to the annual value of $11.0 billion for FY2024, which is 11.66% up from last year.
  • Vertex Pharmaceuticals' Revenue amounted to $11.0 billion in FY2024, which was up 11.66% from $9.9 billion recorded in FY2023.
  • Vertex Pharmaceuticals' Revenue's 5-year high stood at $11.0 billion during FY2024, with a 5-year trough of $6.2 billion in FY2020.
  • In the last 3 years, Vertex Pharmaceuticals' Revenue had a median value of $9.9 billion in 2023 and averaged $9.9 billion.
  • Data for Vertex Pharmaceuticals' Revenue shows a peak YoY spiked of 49.08% (in 2020) over the last 5 years.
  • Vertex Pharmaceuticals' Revenue (Yearly) stood at $6.2 billion in 2020, then rose by 22.06% to $7.6 billion in 2021, then climbed by 17.91% to $8.9 billion in 2022, then rose by 10.51% to $9.9 billion in 2023, then grew by 11.66% to $11.0 billion in 2024.